Can Teens Take Zepbound? What Parents Need to Know

Introduction

The rise of GLP-1 medications has fundamentally changed the conversation around metabolic health and weight management. For parents watching a teenager struggle with weight-related health issues, these new clinical options offer a glimmer of hope, but they also bring significant questions regarding safety and eligibility. You might find yourself wondering if the same medications making headlines for adults are appropriate for younger bodies still in the middle of critical developmental stages. At TrimRx, we understand that navigating the world of medical weight loss is often overwhelming, especially when you are seeking the best care for your family. This post covers the current FDA status of Zepbound® for adolescents, the ongoing clinical research into its safety for younger populations, and the alternative options currently available for teens. Our goal is to provide a clear, science-backed perspective to help you make informed decisions alongside a healthcare provider.

For additional context, read our guide to GLP-1 medications for teenagers before discussing treatment options with a qualified specialist.

The Current FDA Status of Zepbound for Teens

As of early 2025, the short answer is that Zepbound® (tirzepatide) is not FDA-approved for use in individuals under the age of 18. The U.S. Food and Drug Administration (FDA) has authorized Zepbound specifically for chronic weight management in adults. This includes adults with obesity (a body mass index or BMI of 30 or higher) or those who are overweight (a BMI of 27 or higher) and also have at least one weight-related medical condition, such as high blood pressure or type 2 diabetes.

While the medication has shown significant results in adult clinical trials, the medical community maintains a high bar for pediatric approval. Children and adolescents are not simply “small adults.” Their metabolic systems, bone density, and hormonal balances are in a state of constant flux. Until dedicated clinical trials prove that the medication is safe and effective for this specific age group, it remains an adult-only prescription.

Quick Answer: Currently, Zepbound is not approved for anyone under 18 years of age. While clinical trials for adolescents are underway, healthcare providers typically look to other FDA-approved medications for teens who meet the criteria for medical weight management.

Adults who want to explore whether a medically supervised program may be appropriate can complete a free eligibility assessment.

Defining Tirzepatide and How It Works

To understand why there is so much interest in this medication, it helps to understand what it is. Zepbound is the brand name for a molecule called tirzepatide. It belongs to a class of drugs known as dual agonists. Specifically, it is a glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist.

In plain English, tirzepatide mimics two different natural hormones produced in the gut. These hormones are released after you eat and signal to the brain that you are full. They also slow down the speed at which your stomach empties and help the body regulate blood sugar levels. Because tirzepatide targets two hormone pathways instead of just one, it has shown high levels of effectiveness in reducing appetite and supporting weight loss in adult populations.

For a broader overview, read about how GLP-1 medications work in weight management.

The Role of GIP and GLP-1

• GLP-1 (Glucagon-like Peptide-1): This hormone focuses on the “fullness” signal in the brain and slows gastric emptying.
• GIP (Glucose-dependent Insulinotropic Polypeptide): This hormone may help improve how the body breaks down sugar and fat, potentially complementing the effects of GLP-1.

Why the Age Limit Exists for Zepbound

The primary reason Zepbound is restricted to adults is the lack of long-term data on how it affects “growing bodies.” Adolescence is a period of rapid skeletal growth, brain development, and hormonal shifts. Researchers must be certain that a medication does not interfere with these vital processes before the FDA grants approval for pediatric use.

For a medication to be approved for teens, manufacturers must conduct specific trials, such as the SURMOUNT-ADOLESCENTS study. These trials look for several key indicators:

1. Safety: Does the medication cause different or more severe side effects in teens than in adults?
2. Growth and Development: Does it impact height, bone density, or the timing of puberty?
3. Efficacy: Does the medication result in healthy weight reduction for teens when combined with lifestyle changes?

Until these studies are completed and reviewed by federal regulators, Zepbound remains off-limits for the teenage population in a standard clinical setting.

Parents can also review this detailed guide to Zepbound and adolescent eligibility for more background.

FDA-Approved Alternatives for Teens

While Zepbound is currently an adult-only medication, it is not the only option in the GLP-1 category. The FDA has already approved other similar medications for adolescents aged 12 to 17 who meet specific health criteria. These medications have undergone the rigorous pediatric testing mentioned above.

The two primary options for teens are Wegovy® and Saxenda®.

Wegovy (Semaglutide)

Wegovy® is a once-weekly injection that uses semaglutide. Semaglutide is a GLP-1 receptor agonist, meaning it mimics one of the two hormones targeted by Zepbound. In clinical trials involving teens, those taking Wegovy alongside lifestyle modifications saw significant reductions in BMI compared to those making lifestyle changes alone.

Saxenda (Liraglutide)

Saxenda® was the first GLP-1 medication approved for teens aged 12 and older. Unlike the weekly injections, Saxenda is a daily injection. It also mimics the GLP-1 hormone to help regulate appetite. While it is generally considered less potent than semaglutide, it has a long track record of safety in adolescent populations.

For more discussion of pediatric treatment considerations, read our article on whether teenagers should take weight loss medication.

Comparing Weight Loss Medications for Teens

Medication	Active Ingredient	Frequency	FDA Approved for 12-17?
Zepbound®	Tirzepatide	Weekly	No (Adults Only)
Wegovy®	Semaglutide	Weekly	Yes
Saxenda®	Liraglutide	Daily	Yes
Mounjaro®	Tirzepatide	Weekly	Yes (For Type 2 Diabetes only, not weight loss)

Note: It is important to distinguish between medications for weight loss and those for diabetes. Mounjaro®, which contains the same active ingredient as Zepbound, is approved for teens as young as 10 for the treatment of type 2 diabetes, but it is not approved for weight loss in that age group.

Eligibility Criteria for Adolescents

Even for the medications that are approved for teens, the criteria for a prescription are very specific. These medications are not intended for minor cosmetic weight loss. They are medical interventions for a chronic disease.

A healthcare provider will typically only consider a GLP-1 medication for a teen if they meet the following benchmarks:

1. BMI Percentile: The teen must have a BMI at or above the 95th percentile for their age and sex. This is the clinical definition of obesity in children and adolescents.
2. Failed Lifestyle Changes: The family should have already attempted structured lifestyle modifications—such as nutrition counseling and increased physical activity—without seeing adequate health improvements.
3. Presence of Comorbidities: In many cases, a doctor looks for weight-related health issues, such as high cholesterol, prediabetes, or sleep apnea, as further justification for medical intervention.

The Importance of Professional Guidance

Starting a teen on a metabolic medication is a major decision that requires a partnership between the family and a qualified medical team. At TrimRx, we emphasize that weight management should always be personalized to the individual’s unique health profile. For adults, we facilitate this through our telehealth platform, but for teenagers, a multi-disciplinary approach is often required.

A teen’s care team often includes:

• A Pediatrician or Adolescent Medicine Specialist: To monitor growth, puberty, and overall physical health.
• A Registered Dietitian: To ensure the teen is getting enough protein and nutrients while their appetite is suppressed.
• A Mental Health Professional: To support the teen’s relationship with their body and food during the transition.

For adults considering supervised telehealth care, learn how the GLP-1 treatment process works.

Key Takeaway: Medication is a tool, not a standalone fix. For teens, this tool must be managed by specialists who can monitor the delicate balance of growth and metabolic change.

Potential Risks and Side Effects in Teens

The side effects of GLP-1 medications in teens are generally similar to those seen in adults, but they can be more challenging for a young person to manage. Because these drugs slow digestion, the most common issues are gastrointestinal in nature.

Common Side Effects:

• Nausea and vomiting
• Diarrhea or constipation
• Stomach pain or bloating
• Fatigue

For teenagers, there are also specific concerns regarding nutrition. Because these medications significantly reduce hunger, a teen might not consume enough calories or essential nutrients required for growth. Research suggests that some young people on these medications may be at risk for vitamin D deficiencies or muscle loss if they do not prioritize protein intake and strength-building activities.

For additional nutrition guidance, read about protein needs while taking a GLP-1 medication.

Note: If a teen experiences severe abdominal pain, persistent vomiting, or signs of an allergic reaction while on a prescribed weight loss medication, seek medical attention immediately.

The Role of Compounded Medications

In the current landscape of weight loss medicine, you may hear about “compounded” versions of semaglutide or tirzepatide. It is vital to understand the distinction between branded medications and compounded ones.

Compounded medications are custom-made by pharmacists to meet the needs of a specific patient. While they contain the same active ingredients as the branded drugs, compounded semaglutide and compounded tirzepatide are NOT FDA-approved. At TrimRx, we work with FDA-registered and inspected compounding pharmacies to provide access for adults, but the clinical guidelines for using these formulations in teenagers are even more stringent than those for branded products. Most experts recommend sticking to FDA-approved branded options (like Wegovy) for adolescents to ensure the highest level of regulatory oversight.

Lifestyle: The Foundation of Success

Regardless of whether a medication is used, healthy habits remain the foundation of any weight loss journey. For a teenager, these habits are about more than just “dieting”—they are about building a sustainable lifestyle that supports long-term health.

A successful program for a teen usually involves:

• Protein-First Nutrition: Ensuring the body has the building blocks for muscle and bone growth.
• Functional Movement: Moving the body in ways that feel good and build strength, rather than just focused on calorie burning.
• Sleep Hygiene: Crucial for hormonal regulation and metabolic health.
• Hydration: Especially important when taking medications that can cause nausea or changes in digestion.

Families seeking broader guidance can review this nutrition guide for people using weight loss injections.

How to Talk to Your Teen About Weight and Medication

If you are considering a medical weight loss path for your child, the way you frame the conversation is critical. Adolescence is a time of high vulnerability regarding body image. Shaming or focusing solely on “looks” can lead to negative psychological outcomes.

Instead, focus the conversation on:

1. Health and Energy: Frame the medication as a way to help their body work more efficiently so they have the energy to do the things they love.
2. Biology, Not Willpower: Explain that for some people, the brain’s hunger signals are turned up too high, and the medication helps turn them back to a normal level. This removes the “fault” from the teenager.
3. Collaborative Decision Making: Involve your teen in the process. Ask them how they feel about their health and what they hope to achieve.

Bottom line: A health-first, blame-free approach is essential when discussing medical weight management with a teenager.

The Future of Zepbound for Adolescents

The medical world is watching the SURMOUNT-ADOLESCENTS trials very closely. These studies are specifically testing tirzepatide in children and teens aged 12 to 17. If these trials demonstrate that Zepbound is safe and effective for this age group, Eli Lilly (the manufacturer) will likely apply for an expanded FDA approval.

We could see Zepbound become an option for teens in the near future, potentially offering a more potent alternative for those who do not respond to currently approved options. For now, however, patience and adherence to current FDA guidelines are the safest paths.

Our Approach to Personalized Weight Loss

While TrimRx currently focuses on providing personalized, medically supervised programs for adults, we believe that everyone deserves a science-backed, empathetic approach to metabolic health. We merge clinical expertise with modern telehealth technology to ensure that our adult members have 24/7 access to specialists and medications shipped from regulated pharmacies.

For the parents reading this who are on their own weight loss journey, we offer a streamlined process to see if GLP-1 medications are a fit for you. For your children, we encourage you to use this information as a bridge to a deeper conversation with your family pediatrician.

Adults interested in exploring prescription options can see if they qualify for a personalized program.

Conclusion

While Zepbound is not currently approved for teenagers, the landscape of adolescent weight management is expanding rapidly. For teens who meet the medical criteria, medications like Wegovy and Saxenda provide evidence-based options that can be life-changing when managed by the right medical team. Understanding the difference between these treatments and the clinical necessity of professional supervision is the first step toward a healthier future for your child.

• Zepbound is only FDA-approved for adults 18 and older.
• Wegovy and Saxenda are approved for teens aged 12–17 with obesity.
• Medication must be combined with lifestyle changes and nutritional support.
• Always consult a pediatric specialist before starting any weight loss medication.

Key Takeaway: The best next step for a parent is to schedule a dedicated consultation with an adolescent medicine specialist to discuss the full spectrum of metabolic health options.

For adults interested in exploring their own eligibility for a personalized weight loss program, you can begin with a free assessment quiz to learn more about our medically supervised options.

FAQ

When will Zepbound be approved for teens?

There is no confirmed date for when Zepbound might receive FDA approval for teenagers. It depends entirely on the completion and results of ongoing clinical trials like SURMOUNT-ADOLESCENTS, which are currently evaluating the drug’s safety and efficacy in the 12–17 age group.

Is Mounjaro the same as Zepbound for teens?

While both Mounjaro and Zepbound contain tirzepatide, Mounjaro is FDA-approved for teens as young as 10 specifically for treating type 2 diabetes. Zepbound is currently only approved for weight loss in adults; using it for weight loss in teens would be considered an off-label use that must be strictly managed by a doctor.

Can a teen take Wegovy if they don’t qualify for Zepbound?

Yes, Wegovy is FDA-approved for adolescents aged 12 to 17 who have a BMI at or above the 95th percentile for their age and sex. Because it has been specifically studied in this age group and has received regulatory approval, it is the primary weekly GLP-1 option for teens today.

For adults seeking to understand whether prescription treatment may be appropriate, they can complete a free eligibility assessment.

What are the long-term effects of GLP-1s on teenagers?

Because the approval for GLP-1 use in teens is relatively recent, we do not yet have decades of data on long-term effects. Current research shows they are effective for weight reduction and improving metabolic markers like blood sugar, but ongoing monitoring is required to ensure they do not impact long-term growth or bone density.

Disclaimer: This content is for informational purposes only and does not constitute medical advice. It is not intended to diagnose, treat, cure, or prevent any disease or condition. Individual results may vary. Always consult a qualified healthcare professional before starting any weight loss program or medication.